Nyxoah’s Genio Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule
Assignment to New Technology APC 1580 is positive news for Nyxoah’s US commercial rollout.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
